Scinai Immunotherapeutics Statistics

Total Valuation

SCNI has a market cap or net worth of $993,908. The enterprise value is $1.53 million.

Market Cap	993,908
Enterprise Value	1.53M

Important Dates

The last earnings date was Wednesday, April 1, 2026, before market open.

Earnings Date	Apr 1, 2026
Ex-Dividend Date	n/a

Share Statistics

SCNI has 3.96 million shares outstanding. The number of shares has increased by 140.86% in one year.

Current Share Class	n/a
Shares Outstanding	3.96M
Shares Change (YoY)	+140.86%
Shares Change (QoQ)	+23.00%
Owned by Insiders (%)	10.59%
Owned by Institutions (%)	3.19%
Float	3.54M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.82
Forward PS	n/a
PB Ratio	0.14
P/TBV Ratio	0.16
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.26
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.30.

Current Ratio	1.35
Quick Ratio	1.16
Debt / Equity	0.30
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-17.92

Financial Efficiency

Return on equity (ROE) is -29.19% and return on invested capital (ROIC) is -38.62%.

Return on Equity (ROE)	-29.19%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-38.62%
Return on Capital Employed (ROCE)	-56.64%
Weighted Average Cost of Capital (WACC)	11.73%
Revenue Per Employee	$26,978
Profits Per Employee	-$70,511
Employee Count	45
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -90.04% in the last 52 weeks. The beta is 2.05, so SCNI's price volatility has been higher than the market average.

Beta (5Y)	2.05
52-Week Price Change	-90.04%
50-Day Moving Average	0.48
200-Day Moving Average	0.87
Relative Strength Index (RSI)	26.28
Average Volume (20 Days)	431,618

Short Selling Information

The latest short interest is 97,738, so 2.48% of the outstanding shares have been sold short.

Short Interest	97,738
Short Previous Month	157,814
Short % of Shares Out	2.48%
Short % of Float	n/a
Short Ratio (days to cover)	0.41

Income Statement

In the last 12 months, SCNI had revenue of $1.21 million and -$3.17 million in losses. Loss per share was -$1.13.

Revenue	1.21M
Gross Profit	-4.00M
Operating Income	-8.44M
Pretax Income	-3.17M
Net Income	-3.17M
EBITDA	-6.92M
EBIT	-8.44M
Loss Per Share	-$1.13

Full Income Statement

Balance Sheet

The company has $2.96 million in cash and $3.50 million in debt, giving a net cash position of -$533,000 or -$0.13 per share.

Cash & Cash Equivalents	2.96M
Total Debt	3.50M
Net Cash	-533,000
Net Cash Per Share	-$0.13
Equity (Book Value)	11.76M
Book Value Per Share	1.73
Working Capital	929,000

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$6.45 million and capital expenditures -$18,000, giving a free cash flow of -$6.46 million.

Operating Cash Flow	-6.45M
Capital Expenditures	-18,000
Depreciation & Amortization	1.52M
Net Borrowing	n/a
Free Cash Flow	-6.46M
FCF Per Share	-$1.63

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-695.30%
Pretax Margin	-261.37%
Profit Margin	-261.37%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SCNI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-140.86%
Shareholder Yield	-140.86%
Earnings Yield	-319.24%
FCF Yield	-650.36%

Analyst Forecast

The average price target for SCNI is $700.00, which is 278,784.46% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$700.00
Price Target Difference	278,784.46%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (3Y)	118.93%
EPS Growth Forecast (3Y)	n/a

Stock Splits

The last stock split was on May 21, 2024. It was a reverse split with a ratio of 1:10.

Last Split Date	May 21, 2024
Split Type	Reverse
Split Ratio	1:10

Scores

SCNI has an Altman Z-Score of -10.89. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-10.89
Piotroski F-Score	n/a